NCT06285565

Brief Summary

The goal of this pilot interventional study is to assess the feasibility and acceptability of a supportive intervention for patients affected by heart failure. The main questions it aims to answer are:

  • Are implementation strategies effective in facilitating participant fidelity?
  • What factors contribute to patients' satisfaction with the designed intervention, and how can these be optimized for improved patient experience and adherence?
  • Are the methods and tools established the most appropriate to ensure the completeness of the data collection? Participants will follow a combined intervention consisting of:
  • pre-discharge educational meeting;
  • telephone nurse-led coaching sessions;
  • home telemonitoring of vital signs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

September 17, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

February 6, 2024

Last Update Submit

March 4, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Recruitment rate

    the proportion of patients who agreed to participate relative to those who fulfilled the inclusion criteria.

    6 months

  • Retention rate

    the proportion of patients who complete the study and those who consent to participate

    6 months

  • Adherence to the coaching intervention

    the number of coaching phone calls scheduled and actualized

    4 months.

  • Adherence to telemonitoring program

    the proportion of days during which vital signs were measured and sent by the system relative to the total duration of the intervention

    4 months.

  • Completeness of data collection

    number of returned questionnaires.

    baseline, after 3 and 6 months

Secondary Outcomes (12)

  • 90- and 180-day all-cause hospital readmissions

    Data collection is planned at 3 and 6 months.

  • 90- and 180-day heart failure-related hospital readmissions

    Data collection is planned at 3 and 6 months.

  • 90- and 180-day Emergency Departments visits

    Data collection is planned at 3 and 6 months.

  • 90- and 180-day General Practioner visits

    Data collection is planned at 3 and 6 months.

  • 90- and 180-day oupatient visits

    Data collection is planned at 3 and 6 months.

  • +7 more secondary outcomes

Study Arms (2)

Nurse-led supported group

EXPERIMENTAL

A supportive program consisting of the following elements will be provided: 1. Pre-discharge educational meeting. After the patient is deemed stable, an in-hospital educational intervention will be provided by a trained nurse not involved in the clinical pathway. Key topics of self-care management recognized by the European Society of Cardiology will be discussed. 2. Telephone nurse-led coaching sessions. In this phase, patients will be encouraged to focus on their values and progress towards their goals. The intervention will be customized based on the objectives identified during the initial meeting. The scheduled sessions will occur weekly during the first months and then transition to twice a month thereafter. 3. Patients will receive education on measuring weight, blood pressure, heart rate, and oxygen saturation at rest, every morning before breakfast. All participants will be provided with a telemonitoring system that transmits data to a web platform via Bluetooth.

Combination Product: Nurse-led telephone coaching intervention with home telemonitoring of vital signs

Controlled group

NO INTERVENTION

The controlled group will receive usual care

Interventions

In addition to standard care, the intervention group will receive a nurse-led supportive programme that involves a pre-discharge educational meeting and 6-month telephone coaching sessions. Patient's caregivers will also be invited to participate. After discharge, patients will be asked to measure their vital signs, daily. In case of alteration, the nurse will ascertain the presence of congestion symptoms and decide to reinforce the recommendations for self-management, request a specialist medical consultant, or refer to the emergency services

Nurse-led supported group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • aged 65 and over
  • hospitalized for cardiac decompensation, regardless of ejection fraction (FE) value (preserved or decreased)
  • expected to be discharged home will be considered eligible.

You may not qualify if:

  • Individuals who lack the cognitive and/or physical capabilities (Mini-COG +) for self-monitoring of vital signs, and without a caregiver available to assist them
  • people who receive other medical services

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Azienda Ospedaliero-Universitaria maggiore della Carità di Novara

Novara, Novara, 28100, Italy

Location

Università del Piemonte Orientale Amedeo Avogadro

Novara, Novara, 28100, Italy

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • INES BASSO, Dr

    Università degli Studi del Piemonte Orientale Amedeo Avogadro

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessors will collect clinical outcomes by telephone and will be blinded to the group assignment
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A parallel, open-label randomized controlled feasibility study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 29, 2024

Study Start

September 17, 2024

Primary Completion

December 15, 2025

Study Completion

December 15, 2025

Last Updated

March 5, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations